ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 1 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $13,890,068,000 | +55.2% | 149,452 | -0.6% | 0.01% | +25.0% |
| Q3 2021 | $8,950,961,000 | -15.0% | 150,310 | -2.7% | 0.00% | -20.0% |
| Q2 2021 | $10,531,034,000 | -2.7% | 154,414 | -1.1% | 0.01% | 0.0% |
| Q1 2021 | $10,828,655,000 | -64.5% | 156,055 | -60.7% | 0.01% | -64.3% |
| Q4 2020 | $30,514,724,000 | +148.3% | 397,172 | +141.7% | 0.01% | +100.0% |
| Q3 2020 | $12,290,615,000 | +23.8% | 164,335 | +4.2% | 0.01% | +16.7% |
| Q2 2020 | $9,929,420,000 | +326.5% | 157,735 | +184.5% | 0.01% | +200.0% |
| Q1 2020 | $2,328,354,000 | -7.1% | 55,437 | +0.4% | 0.00% | 0.0% |
| Q4 2019 | $2,506,820,000 | +2.2% | 55,192 | +3.0% | 0.00% | 0.0% |
| Q3 2019 | $2,453,134,000 | +3.2% | 53,597 | +32.3% | 0.00% | 0.0% |
| Q2 2019 | $2,376,098,000 | +42.1% | 40,527 | +8.6% | 0.00% | +100.0% |
| Q1 2019 | $1,672,427,000 | +20.1% | 37,306 | +4.3% | 0.00% | 0.0% |
| Q4 2018 | $1,392,969,000 | -5.5% | 35,763 | +11.7% | 0.00% | 0.0% |
| Q3 2018 | $1,473,607,000 | +5.6% | 32,021 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,396,115,000 | +75.9% | 32,021 | +59.3% | 0.00% | 0.0% |
| Q1 2018 | $793,793,000 | +62.4% | 20,096 | +39.7% | 0.00% | – |
| Q4 2017 | $488,693,000 | – | 14,386 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
| PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
| Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
| Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
| DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
| Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
| First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
| Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
| Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
| Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |